Replimune stock plunges after FDA rejects melanoma treatment application

4 months ago 17
Read Entire Article
  1. Homepage
  2. Finance
  3. Replimune stock plunges after FDA rejects melanoma treatment application

Related

America's Car-Mart shares rise 2% despite earnings miss as capital restructuring progresses

America's Car-Mart shares rise 2% despite earnings miss as c...

56 minutes ago 1
Broadstone Net Lease stock rating reiterated at Overweight by Cantor Fitzgerald

Broadstone Net Lease stock rating reiterated at Overweight b...

56 minutes ago 1
Goldman Sachs initiates coverage on ORIC stock with Early-Stage Biotech rating

Goldman Sachs initiates coverage on ORIC stock with Early-St...

56 minutes ago 1

Trending

1. economic calendar
2. taylor lewan
3. winter weather warnings
4. gma deals and steals today
5. michael dell net worth
6. sigourney weaver
7. nikodem marecki
8. rosalia tour
9. pantone color of the year 2026
10. babson college

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

10 months ago 623
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

8 months ago 492
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

9 months ago 354
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

11 months ago 311
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

9 months ago 311
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved